Evidence for the Prevention and Treatment of Stroke in Dialysis Patients
暂无分享,去创建一个
[1] Bill Bynum,et al. Lancet , 2015, The Lancet.
[2] P. Sandercock,et al. Effect of treatment delay, age, and stroke severity on the effects of intravenous thrombolysis with alteplase for acute ischaemic stroke: a meta-analysis of individual patient data from randomised trials | NOVA. The University of Newcastle's Digital Repository , 2014 .
[3] Jung-Der Wang,et al. Risk of stroke in long-term dialysis patients compared with the general population. , 2014, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[4] S. Kasner,et al. Endocarditis Is a Common Stroke Mechanism in Hemodialysis Patients , 2014, Stroke.
[5] J. Tu,et al. Warfarin Use and the Risk for Stroke and Bleeding in Patients With Atrial Fibrillation Undergoing Dialysis , 2014, Circulation.
[6] Alexander Parkhomenko,et al. Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials , 2014, The Lancet.
[7] J. Carrero,et al. Warfarin, kidney dysfunction, and outcomes following acute myocardial infarction in patients with atrial fibrillation. , 2014, JAMA.
[8] V. Chair,et al. Guidelines for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. , 2014, Stroke.
[9] P. Kalra,et al. Meta-Analysis of Lipid-Lowering Therapy in Maintenance Dialysis Patients , 2014, Nephron Clinical Practice.
[10] D. Wheeler,et al. Acute Stroke Thrombolysis in End-Stage Renal Disease: A National Survey of Nephrologist Opinion , 2013, Nephron Clinical Practice.
[11] J. Eikelboom,et al. Stroke prevention in atrial fibrillation patients with chronic kidney disease. , 2013, The Canadian journal of cardiology.
[12] A. Murray,et al. Incidence of stroke before and after dialysis initiation in older patients. , 2013, Journal of the American Society of Nephrology : JASN.
[13] A. Martínez‐Castelao,et al. High-efficiency postdilution online hemodiafiltration reduces all-cause mortality in hemodialysis patients. , 2013, Journal of the American Society of Nephrology : JASN.
[14] M. Wintermark,et al. Guidelines for the Early Management of Patients With Acute Ischemic Stroke: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association , 2013, Stroke.
[15] H. Woo,et al. Low Glomerular Filtration Rate Increases Hemorrhagic Transformation in Acute Ischemic Stroke , 2013, Cerebrovascular Diseases.
[16] Bernadette A. Thomas,et al. Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010 , 2012, The Lancet.
[17] Bernadette A. Thomas,et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010 , 2012, The Lancet.
[18] K. Mahaffey,et al. Effect of cinacalcet on cardiovascular disease in patients undergoing dialysis. , 2012, The New England journal of medicine.
[19] N. Ansari,et al. Cerebrovascular Accident Secondary to Paradoxical Embolism Following Arteriovenous Graft Thrombectomy , 2012, Case reports in nephrology.
[20] L. Køber,et al. Stroke and bleeding in atrial fibrillation with chronic kidney disease. , 2012, The New England journal of medicine.
[21] D. Coyne. The health-related quality of life was not improved by targeting higher hemoglobin in the Normal Hematocrit Trial , 2012, Kidney international.
[22] Chun-Yuh Yang,et al. Haemodialysis and the risk of stroke: A population‐based cohort study in Taiwan, a country of high incidence of end‐stage renal disease , 2012, Nephrology.
[23] N. Duncan,et al. Appraising stroke risk in maintenance hemodialysis patients: a large single-center cohort study. , 2012, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[24] H. Uno,et al. Stroke in Patients With Type 2 Diabetes Mellitus, Chronic Kidney Disease, and Anemia Treated With Darbepoetin Alfa: The Trial to Reduce Cardiovascular Events With Aranesp Therapy (TREAT) Experience , 2011, Circulation.
[25] W. Winkelmayer,et al. Effectiveness and safety of warfarin initiation in older hemodialysis patients with incident atrial fibrillation. , 2011, Clinical journal of the American Society of Nephrology : CJASN.
[26] R. Foley,et al. Long interdialytic interval and mortality among patients receiving hemodialysis. , 2011, The New England journal of medicine.
[27] Bertram L Kasiske,et al. Cardiovascular disease in chronic kidney disease. A clinical update from Kidney Disease: Improving Global Outcomes (KDIGO). , 2011, Kidney international.
[28] F. Zannad,et al. Rosuvastatin in diabetic hemodialysis patients. , 2011, Journal of the American Society of Nephrology : JASN.
[29] M. Landray,et al. The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trial , 2011, The Lancet.
[30] N. Powe,et al. Inflammatory markers and risk of cerebrovascular events in patients initiating dialysis. , 2011, Clinical journal of the American Society of Nephrology : CJASN.
[31] D. Goldsmith,et al. Renal Association Clinical Practice Guideline on Cardiovascular Disease in CKD , 2011, Nephron Clinical Practice.
[32] R. Hart,et al. Thrombolysis for acute stroke in hemodialysis: international survey of expert opinion. , 2011, Clinical journal of the American Society of Nephrology : CJASN.
[33] K. Iseki,et al. Elevated non-high-density lipoprotein cholesterol (non-HDL-C) predicts atherosclerotic cardiovascular events in hemodialysis patients. , 2011, Clinical journal of the American Society of Nephrology : CJASN.
[34] G. Lip,et al. Severe renal impairment and stroke prevention in atrial fibrillation: implications for thromboprophylaxis and bleeding risk. , 2011, Journal of the American College of Cardiology.
[35] A. Hayen,et al. Serum levels of phosphorus, parathyroid hormone, and calcium and risks of death and cardiovascular disease in individuals with chronic kidney disease: a systematic review and meta-analysis. , 2011, JAMA.
[36] B. Ovbiagele. Chronic kidney disease and risk of death during hospitalization for stroke , 2011, Journal of the Neurological Sciences.
[37] W. Winkelmayer,et al. The increasing prevalence of atrial fibrillation among hemodialysis patients. , 2011, Journal of the American Society of Nephrology : JASN.
[38] Seemant Chaturvedi,et al. Guidelines for the Primary Prevention of Stroke: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association , 2011, Stroke.
[39] M. Drazner. Contemporary Reviews in Cardiovascular Medicine The Progression of Hypertensive Heart Disease , 2011 .
[40] Irene Katzan,et al. Guidelines for the prevention of stroke in patients with stroke or transient ischemic attack: a guideline for healthcare professionals from the american heart association/american stroke association. , 2011, Stroke.
[41] G. Beck,et al. In-center hemodialysis six times per week versus three times per week. , 2010, The New England journal of medicine.
[42] C. Zoccali,et al. Traditional and nontraditional risk factors as predictors of cerebrovascular events in patients with end stage renal disease , 2010, Journal of hypertension.
[43] M. Gnant,et al. Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170 000 participants in 26 randomised trials , 2010 .
[44] R. Collins,et al. Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170 000 participants in 26 randomised trials , 2010, The Lancet.
[45] M. Polaina,et al. Ischaemic stroke in incident dialysis patients. , 2010, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[46] Michael D Hill,et al. Stenting versus endarterectomy for treatment of carotid-artery stenosis. , 2010, The New England journal of medicine.
[47] J. Danesh,et al. Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies. , 2010, Lancet.
[48] P. Kerr,et al. Atrial fibrillation in hemodialysis patients: clinical features and associations with anticoagulant therapy. , 2010, Kidney international.
[49] R. Foley,et al. Left ventricular hypertrophy in new hemodialysis patients without symptomatic cardiac disease. , 2010, Clinical journal of the American Society of Nephrology : CJASN.
[50] Kevin A Peterson,et al. Effects of Intensive Blood-Pressure Control in Type 2 Diabetes Mellitus , 2011 .
[51] D. Mozaffarian,et al. Heart disease and stroke statistics--2010 update: a report from the American Heart Association. , 2010, Circulation.
[52] R. Garrick. A Trial of Darbepoetin Alfa in Type 2 Diabetes and Chronic Kidney Disease , 2010 .
[53] G. Moneta,et al. Major Lipids, Apolipoproteins, and Risk of Vascular Disease , 2010 .
[54] W. Elliott. Effect of lowering blood pressure on cardiovascular events and mortality in patients on dialysis: a systematic review and meta-analysis of randomised controlled trials , 2010 .
[55] R. Zarychanski,et al. Dabigatran versus warfarin in patients with atrial fibrillation. , 2009, The New England journal of medicine.
[56] S. Yusuf,et al. Dabigatran versus warfarin in patients with atrial fibrillation. , 2009, The New England journal of medicine.
[57] J. Craig,et al. Benefits and harms of phosphate binders in CKD: a systematic review of randomized controlled trials. , 2009, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[58] R. Thadhani,et al. Warfarin use associates with increased risk for stroke in hemodialysis patients with atrial fibrillation. , 2009, Journal of the American Society of Nephrology : JASN.
[59] N. Powe,et al. Cerebrovascular disease incidence, characteristics, and outcomes in patients initiating dialysis: the choices for healthy outcomes in caring for ESRD (CHOICE) study. , 2009, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[60] P. Castellano,et al. Atrial fibrillation in incident dialysis patients. , 2009, Kidney international.
[61] R. Collins,et al. Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials , 2009, The Lancet.
[62] N J Wald,et al. Use of blood pressure lowering drugs in the prevention of cardiovascular disease: meta-analysis of 147 randomised trials in the context of expectations from prospective epidemiological studies , 2009, BMJ : British Medical Journal.
[63] Gert Mayer,et al. Rosuvastatin and cardiovascular events in patients undergoing hemodialysis. , 2009, The New England journal of medicine.
[64] D. Grobbee,et al. Effect of lowering blood pressure on cardiovascular events and mortality in patients on dialysis: a systematic review and meta-analysis of randomised controlled trials , 2009, The Lancet.
[65] D. Singer,et al. Impact of Proteinuria and Glomerular Filtration Rate on Risk of Thromboembolism in Atrial Fibrillation: The Anticoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study , 2009, Circulation.
[66] Z. Massy,et al. High prevalence of intracranial artery calcification in stroke patients with CKD: a retrospective study. , 2009, Clinical journal of the American Society of Nephrology : CJASN.
[67] M. Olschewski,et al. Electrocardiography and outcome in patients with diabetes mellitus on maintenance hemodialysis. , 2009, Clinical journal of the American Society of Nephrology : CJASN.
[68] S. Mundra,et al. Fibroblast Growth Factor 23 and Mortality among Patients Undergoing Hemodialysis , 2009 .
[69] G. London,et al. Assessment and significance of arterial stiffness in patients with chronic kidney disease , 2008, Current opinion in nephrology and hypertension.
[70] P. Rothwell. Endarterectomy for symptomatic and asymptomatic carotid stenosis. , 2008, Neurologic clinics.
[71] M. Wolf,et al. Fibroblast growth factor 23 and mortality among patients undergoing hemodialysis. , 2008, The New England journal of medicine.
[72] M. Tonelli,et al. Effect of frequent nocturnal hemodialysis vs conventional hemodialysis on left ventricular mass and quality of life: a randomized controlled trial. , 2007, JAMA.
[73] R. Holden,et al. Warfarin anticoagulation in hemodialysis patients: a systematic review of bleeding rates. , 2007, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[74] M. Aguilar,et al. Meta-analysis: Antithrombotic Therapy to Prevent Stroke in Patients Who Have Nonvalvular Atrial Fibrillation , 2007, Annals of Internal Medicine.
[75] Ming Liu,et al. Stroke in China: epidemiology, prevention, and management strategies , 2007, The Lancet Neurology.
[76] H. Burger,et al. Normalization of hemoglobin level in patients with chronic kidney disease and anemia. , 2006, The New England journal of medicine.
[77] C. Sudlow,et al. Is hypertension a more frequent risk factor for deep than for lobar supratentorial intracerebral haemorrhage? , 2006, Journal of Neurology, Neurosurgery & Psychiatry.
[78] C. Zoccali,et al. Pre- and postdialysis blood pressures are imprecise estimates of interdialytic ambulatory blood pressure. , 2006, Clinical journal of the American Society of Nephrology : CJASN.
[79] Daniel R Wong,et al. Defining the high-risk patient for carotid endarterectomy: an analysis of the prospective National Surgical Quality Improvement Program database. , 2006, Journal of vascular surgery.
[80] G. Beck,et al. Cerebrovascular disease in maintenance hemodialysis patients: results of the HEMO Study. , 2006, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[81] G. London. [Arteriosclerosis and arterial calcifications in chronic kidney insufficiency]. , 2005, Nephrologie & therapeutique.
[82] W. März,et al. Atorvastatin in patients with type 2 diabetes mellitus undergoing hemodialysis. , 2005, The New England journal of medicine.
[83] E. Lakatta,et al. Elevated Aortic Pulse Wave Velocity, a Marker of Arterial Stiffness, Predicts Cardiovascular Events in Well-Functioning Older Adults , 2005, Circulation.
[84] S. Ibayashi,et al. Stroke in patients on maintenance hemodialysis: a 22-year single-center study. , 2005, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[85] J. Griffith,et al. Effects of anemia and left ventricular hypertrophy on cardiovascular disease in patients with chronic kidney disease. , 2005, Journal of the American Society of Nephrology : JASN.
[86] Charles E McCulloch,et al. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. , 2004, The New England journal of medicine.
[87] G. Chertow,et al. Mineral metabolism, mortality, and morbidity in maintenance hemodialysis. , 2004, Journal of the American Society of Nephrology : JASN.
[88] S. Ibayashi,et al. Incidence, Etiology, and Outcome of Stroke in Patients on Continuous Ambulatory Peritoneal Dialysis , 2003, Cerebrovascular Diseases.
[89] B. Kestenbaum,et al. Risk factors for incident stroke among patients with end-stage renal disease. , 2003, Journal of the American Society of Nephrology : JASN.
[90] G. London,et al. Arterial media calcification in end-stage renal disease: impact on all-cause and cardiovascular mortality. , 2003, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[91] V. Vaccarino,et al. Chronic kidney disease, anemia, and incident stroke in a middle-aged, community-based population: the ARIC Study. , 2003, Kidney international.
[92] B. Kestenbaum,et al. Elevated risk of stroke among patients with end-stage renal disease. , 2003, Kidney international.
[93] D. Bennett,et al. Blood pressure and cardiovascular disease in the Asia Pacific region. , 2003, Journal of hypertension.
[94] S. Lewington. Prospective studies collaboration. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies (vol 360, pg 1903, 2002) , 2003 .
[95] S. Gutnikov,et al. Analysis of pooled data from the randomised controlled trials of endarterectomy for symptomatic carotid stenosis , 2003, The Lancet.
[96] Alan D. Lopez,et al. The Global Burden of Disease Study , 2003 .
[97] R. Collins,et al. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies , 2002, The Lancet.
[98] W. Hörl,et al. Hemodialysis-associated hypertension: pathophysiology and therapy. , 2002, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[99] A. Mattioli,et al. Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients , 2002, BMJ : British Medical Journal.
[100] Catherine Sudlow,et al. Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients , 2002, BMJ : British Medical Journal.
[101] M. Rich,et al. Validation of clinical classification schemes for predicting stroke: results from the National Registry of Atrial Fibrillation. , 2001, JAMA.
[102] Stephen MacMahon,et al. Reliable assessment of the effects of treatment on mortality and major morbidity, II: observational studies , 2001, The Lancet.
[103] G. Rinkel,et al. Subarachnoid haemorrhage: diagnosis, causes and management. , 2001, Brain : a journal of neurology.
[104] K. Iseki,et al. Clinical demographics and long-term prognosis after stroke in patients on chronic haemodialysis. The Okinawa Dialysis Study (OKIDS) Group. , 2000, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[105] G. Lip,et al. Hypertensive heart disease. A complex syndrome or a hypertensive 'cardiomyopathy'? , 2000, European heart journal.
[106] M. McKee,et al. Phosphate regulation of vascular smooth muscle cell calcification. , 2000, Circulation research.
[107] J. McNeil,et al. Carotid Artery Intima–Medial Thickness Is Increased In Chronic Renal Failure , 2000, Clinical and experimental pharmacology & physiology.
[108] Colin Baigent,et al. Premature cardiovascular disease in chronic renal failure , 2000, The Lancet.
[109] Avid,et al. THE EFFECTS OF NORMAL AS COMPARED WITH LOW HEMATOCRIT VALUES IN PATIENTS WITH CARDIAC DISEASE WHO ARE RECEIVING HEMODIALYSIS AND EPOETIN , 2000 .
[110] R. Collins,et al. Underestimation of risk associations due to regression dilution in long-term follow-up of prospective studies. , 1999, American journal of epidemiology.
[111] R. Wolfe,et al. Predialysis blood pressure and mortality risk in a national sample of maintenance hemodialysis patients. , 1999, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[112] C. Tomson,et al. Calcified plaque is common in the carotid and femoral arteries of dialysis patients without clinical vascular disease. , 1998, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[113] A. Levey,et al. "U" curve association of blood pressure and mortality in hemodialysis patients. Medical Directors of Dialysis Clinic, Inc. , 1998, Kidney international.
[114] Y. Yamamoto,et al. Incidence, outcome, and risk factors of cerebrovascular events in patients undergoing maintenance hemodialysis. , 1998, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[115] K. Iseki,et al. Predictors of stroke in patients receiving chronic hemodialysis. , 1996, Kidney international.
[116] T. Shoji,et al. High-resolution B-mode ultrasonography in evaluation of atherosclerosis in uremia. , 1995, Kidney international.
[117] M. Schroll,et al. Stroke incidence, case fatality, and mortality in the WHO MONICA project. World Health Organization Monitoring Trends and Determinants in Cardiovascular Disease. , 1995, Stroke.
[118] R. Foley,et al. Clinical and echocardiographic disease in patients starting end-stage renal disease therapy. , 1995, Kidney international.
[119] David Lee Gordon,et al. Classification of Subtype of Acute Ischemic Stroke: Definitions for Use in a Multicenter Clinical Trial , 1993, Stroke.
[120] P. Wolf,et al. Atrial fibrillation as an independent risk factor for stroke: the Framingham Study. , 1991, Stroke.
[121] E G Lowrie,et al. Death risk in hemodialysis patients: the predictive value of commonly measured variables and an evaluation of death rate differences between facilities. , 1990, American journal of kidney diseases : the official journal of the National Kidney Foundation.